Meeting
2019 ASCO Annual Meeting
Efficacy of immune checkpoint inhibitors (ICIs) for in-transit melanoma.
Authors
Emilia Nan Tie
Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
Emilia Nan Tie , Julia Elizabeth Lai-Kwon , Lumine Na , Michael Alexander Rtshiladze , James Bozzi , Tavis Read , Victoria Atkinson , George Au-Yeung , Georgina V. Long , Grant A. McArthur , Shahneen Kaur Sandhu , Robyn Saw , Euan Thomas Walpole , Alexander M. Menzies , B. Mark Smithers , David E. Gyorki
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Local-Regional Disease
Citation
J Clin Oncol 37, 2019 (suppl; abstr 9583)
DOI
10.1200/JCO.2019.37.15_suppl.9583
Abstract #
9583
Poster Bd #
154
Abstract Disclosures
Similar Posters
Poster
2020 ASCO-SITC Clinical Immuno-Oncology Symposium
Efficacy and toxicities of immune checkpoint inhibitors (ICIs) in advanced melanoma: A single institution experience.
First Author: Karim Welaya
Poster
2023 ASCO Annual Meeting
A randomized phase 2 trial of encorafenib + binimetinib + nivolumab vs ipilimumab + nivolumab in BRAFV600-mutant melanoma brain metastases: SWOG S2000.
First Author: Zeynep Eroglu
Poster
2023 ASCO Annual Meeting
Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: An AGEO European Cohort.
First Author: Lorenzo Pilla
Poster
2023 ASCO Annual Meeting
Time-dependent efficacy of immune checkpoint inhibitors in the treatment of metastatic cancers: A meta-analysis.
First Author: Thierry Landre